AbbVie to buy Cerevel in $8.7B bet on brain drugs

cafead

Administrator
Staff member
  • cafead   Dec 06, 2023 at 09:52: PM
via AbbVie is restocking its drug pipeline in a big way, announcing Wednesday an $8.7 billion deal to buy neuroscience-focused Cerevel Therapeutics, just days after agreeing to a similar sized acquisition of the cancer biotechnology company ImmunoGen.

article source
 

<